No ordinary shares are being registered hereunder for sale by the company. The company will not receive any proceeds from the sale of the ordinary shares by the selling shareholders.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PLRZ:
- Polyrizon Achieves Milestone with Successful Safety Study of PL-14
- Polyrizon reports safety study results for PL-14 Allergy Blocker formulation
- Polyrizon Ltd. Shareholders Approve Key Amendments at Annual Meeting
- Polyrizon Faces Nasdaq Compliance Challenge
- Polyrizon Partners with Branding Firm for Strategic Brand Development